Hydrocortisone for pancreatitis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 16 Dec 2021: Trial registered, NCT05160506
  2. 6 Mar 2022: Trial started, NCT05160506

The trials

NCT05160506: Corticosteroids to Treat Pancreatitis

State
Under way
Phase
Phase 2
People
86 planned
Started
6 Mar 2022
Primary completion
Jan 2027
Arms
Hydrocortisone
Results
None posted
  1. 16 Dec 2021: Trial registered
  2. 6 Mar 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Acticort, Aeroseb-hc, Ala-cort, Ala-scalp, Alkindi sprinkle, Anusol hc, Balneol-hc, Beta-hc, Cetacort, Colocort, Cort-dome, Cortef, Cortenema, Cortril, Dermacort, Eldecort, Epicort, Glycort, Hydrocortone, Hytone, Khindivi, Nogenic hc, Nutracort, Penecort, Plenadren, Proctocort, Stie-cort, Synacort, Texacort.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.